Concept Therapeutics Caught In the Middle Of A Scandal
Corcept Therapeutics (CORT) shares were down sharply due to a negative report published by the Southern Investigative Reporting Foundation. In the report, the SIRF laid out an argument essentially accusing the company of colluding with physicians to increase prescriptions of its treatment despite the fact that the treatment was only approved by the FDA for […]
Read Article